MELANIE CHOI: Open Payments
NPI 1316566094 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,617 in 88 payments from 18 companies in 2025. Trend: 2023 $1,121 · 2024 $3,045 · 2025 $2,617
Food & beverage: $2,522Education: $96
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $635 |
| Regeneron Healthcare Solutions, Inc. | 13 | $561 |
| ABBVIE INC. | 9 | $223 |
| Arcutis Biotherapeutics, Inc. | 9 | $180 |
| PFIZER INC. | 6 | $155 |
| Lilly USA, LLC | 5 | $133 |
| Incyte Corporation | 5 | $128 |
| Janssen Biotech, Inc. | 4 | $110 |
| Galderma Laboratories, L.P. | 3 | $85 |
| UCB, Inc. | 2 | $73 |
Products named: DUPIXENT, Zoryve, RINVOQ, OPZELURA, TREMFYA, EBGLYSS, CIBINQO, SKYRIZI.
Industry payments across CA — which companies pay providers there.
